Tezepelumab trials for Asthma

All Tezepelumab trials · All Asthma trials

Phase breakdown

Recruiting trials studying Tezepelumab for Asthma

• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
  NCT06023589 · Phase: Phase 3 · Ages: 5 Years to 11 Years · Sex: All (male and female) · 147 locations
• Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
  NCT07363642 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · 75 locations
• Physical Activity Promotion and Clinical Remission in Severe Asthma
  NCT07735494 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
  NCT06705764 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• Tezspire Cardiac Events PASS
  NCT06951867 · Phase: Not specified · Ages: 12 Years to 130 Years · Sex: All (male and female) · 4 locations

Common questions

How many trials study Tezepelumab for Asthma?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.